Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

被引：0

作者：

Thomas Powles

Mark Kockx

Alejo Rodriguez-Vida

Ignacio Duran

Simon J. Crabb

Michiel S. Van Der Heijden

Bernadett Szabados

Albert Font Pous

Gwenaelle Gravis

Urbano Anido Herranz

Andrew Protheroe

Alain Ravaud

Denis Maillet

Maria Jose Mendez

Cristina Suarez

Mark Linch

Aaron Prendergast

Pieter-Jan van Dam

Diana Stanoeva

Sofie Daelemans

Sanjeev Mariathasan

Joy S. Tea

Kelly Mousa

Romain Banchereau

Daniel Castellano

机构：

[1] Queen Mary University of London,Barts Experimental Cancer Medicine Centre, Barts Cancer Institute

[2] HistogeneX N.V,Department of Medical Oncology

[3] Hospital del Mar,Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio

[4] CSIC and Universidad de Sevilla,Southampton Experimental Cancer Medicine Centre

[5] University of Southampton,Department of Medical Oncology

[6] The Netherlands Cancer Institute,Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)

[7] Hospital Universitari Germans Trias i Pujol,IGTP

[8] Institut Paoli-Calmettes,Department of Medical Oncology

[9] Hospital Clinico Universitario de Santiago,Department of Medical Oncology

[10] Churchill Hospital,Department of Medical Oncology, Hopital Saint

[11] University of Bordeaux–CHU Bordeaux,Andre

[12] Hospital Lyon Sud,Department of Medical Oncology

[13] Reina Sofia University Hospital,Department of Medical Oncology

[14] Universitat Autonoma de Barcelona,Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital

[15] University College London Hospital,Department of Medical Oncology

[16] University of Antwerp,Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences

[17] Genentech,Department of Medical Oncology

[18] Hospital 12 de Octubre,undefined

来源：

Nature Medicine | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3271 / 3271